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We present here a dynamic model of functional equilibrium between keratinocyte stem cells, transit amplifying
populations and cells that are reversibly versus irreversibly committed to differentiation. According to this model,
the size of keratinocyte stem cell populations can be controlled at multiple levels, including relative late steps in the
sequence of events leading to terminal differentiation and by the inﬂuences of a heterogeneous extra-cellular
environment. We discuss how work in our laboratory, on the interconnection between the cyclin/CDK inhibitor
p21WAF1/Cip1 and the Notch1 signaling pathways, provides strong support to this dynamic model of stem cell versus
committed and/or differentiated keratinocyte populations.
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Emerging evidence indicates that the balance between ep-
ithelial cell growth and differentiation involves a complex
interplay between classical cell regulatory pathways and
development-related signals. Keratinocytes provide an ideal
experimental system to dissect the extra and intracellular
signaling pathways involved in growth/differentiation control
of epithelial cells, under normal conditions and during tumor
development (Dotto, 1999). Within the proliferative com-
partment of the epidermis, at least two kinds of keratinocyte
populations are thought to exist: multipotent ‘‘stem cells’’,
slow cycling but with an indefinite self renewal potential and
capable of generating all other types of growing and differ-
entiating keratinocytes; and ‘‘transient amplifying cells’’,
actively proliferating but capable of a limited number of cell
divisions and already committed towards differentiation
(Dover and Wright, 1991).
An attractive model, depicted in Fig 1, is that there is a
dynamic equilibrium between keratinocyte stem cells, tran-
sit amplifying populations and cells that are reversibly ver-
sus irreversibly committed to differentiation. According to
this model, the size of stem cell populations is likely to be
influenced by the number of surrounding transit amplifying
cells that are in turn in equilibrium with cells that have with-
drawn reversibly versus irreversibly from the cell cycle. The
rate of conversion from one cell population to the next is
likely to be further controlled by the surrounding cellular
environment, i.e. the stroma and associated blood supply.
Such cellular environment is likely to be non-homogene-
ously distributed, but organized along discontinuous signa-
ling centers that are more (niches) or less permissive for
stem cell populations. It is therefore likely that the number of
keratinocyte stem cells can be controlled through mecha-
nisms acting at multiple levels, including (A) relative late
steps in the sequence of events leading to terminal differ-
entiation; (B) influences of the surrounding cellular and ex-
tracellular environment. Here we will discuss how work in
our laboratory, on the interconnection between the cyclin/
CDK inhibitor p21WAF1/Cip1 and the Notch1 signaling path-
way, which provides strong support to the dynamic model
illustrated above.
Results and Discussion
p21WAF1/Cip1 as a determinant of the balance among
keratinocyte stem cells, transit amplifying and irrevers-
ibly differentiated populations p21WAF1/Cip1 was originally
identified as a mediator of p53-induced growth arrest (el-
Deiry et al, 1993), a direct inhibitor of CDK activity (CKI)
(Harper et al, 1993), and a gene whose expression is in-
duced with cellular senescence (Noda et al, 1994). This
protein belongs to the Cip/Kip family of CKI (p21WAF1/Cip1,
p27Kip1, p57Kip2), which share significant sequence homol-
ogy in their amino-terminal portions and recognize a broad,
but not identical range of cyclin/CDK targets (Sherr and
Figure1
Model of a dynamic equilibrium between keratinocyte populations
with different stem cell potential versus commitment to differen-
tiation.
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Roberts, 1999). The amino terminal domain of p21, like the
corresponding domains of p27 or p57, is both necessary
and sufficient to inhibit cyclin/CDK activity in vitro and
in vivo. The unique carboxy-terminal domain of p21 associ-
ates with the proliferating nuclear antigen (PCNA), a subunit
of DNA polymerase d and can inhibit DNA replication di-
rectly, without affecting DNA repair (Sherr and Roberts,
1999). As we have recently reviewed (Dotto, 2000), besides
associating with cyclin/CDKs and PCNA, p21 participates in
a number of other specific protein–protein interactions.
Some of these interactions still bear on cell cycle control,
whereas others point to separate functions of p21, as a
modulator of apoptosis or transcription.
In keratinocytes, like in other cell types, increased p21
expression plays an important role in cell cycle withdrawal
which is associated with differentiation (Missero et al, 1995).
p21, however, is not absolutely required for this process, as
other cell cycle regulatory events are associated with the
differentiation process that can compensate for lack of p21
function (Missero et al, 1996). The vast majority of growing
keratinocytes correspond to ‘‘transit amplifying’’ cells (Do-
ver and Wright, 1991). In contrast to the transition between
growth and growth arrest of these ‘‘transit amplifying’’ pop-
ulations, we have found that p21 is likely to play an essential
role in restricting the number of keratinocytes with high
growth/differentiation potential (putative stem cells). Several
lines of evidence support this conclusion.
Like in other organ systems, keratinocyte stem cells are
only a small fraction of cells in the epidermis, with no
unequivocal biochemical markers, so that their analysis is
ultimately dependent on functional rather than biochemical
assays. Stem cells should have two fundamental properties:
(1) an indefinite life span, and (2) the capability to give rise to
all other types of partially committed and differentiated
cells. The existence of keratinocyte subpopulations with in-
creased growth potential, capable of generating rapidly ex-
panding colonies in culture has been well established (Watt
and Hogan, 2000). Primary keratinocytes derived from
p21/ mice undergo growth in arrest in response to in-
creased extracellular calcium to a same extent as wild type
cells (Missero et al, 1996). When tested in a growth clono-
genicity assays, however, p21/ keratinocyte cultures
contain a much higher fraction of keratinocytes with clono-
genic properties than their wild type counterpart (0.1%
of total proliferating cells, vs o0.005%) (Topley et al, 1999).
Keratinocytes in the interfollicular epidermis undergo a
vertical differentiation program along a single lineage. By
contrast, keratinocyte differentiation in hair follicles pro-
ceeds along a minimum of six distinct lineages (Chase,
1965). To take into account this complex program of differ-
entiation, we developed an in vivo skin/hair reconstitution
assay with genetically labeled cells. The interfollicular ep-
idermis reconstituted in these assays was composed of
well-demarcated columnar units likely to originate from sin-
gle progenitor cells. By contrast, reconstituted hair follicles
were composed of cells of multiple origin, consistent with
distinct progenitor cells for the shaft, inner (IRS) and outer
root sheath (ORS), respectively (Kamimura et al, 1997). Al-
though the existence of multipotent progenitor cells capable
of reconstituting entire hair follicles has been well demon-
strated in vivo (Taylor et al, 2000; Oshima et al, 2001), in our
combined in vitro/in vivo assay with cultured wild-type
keratinocytes, very few if any multipotent precursor cells ca-
pable to generate on their own entire hair follicles could be
detected (Kamimura et al, 1997). By contrast, the presence
of such multipotent progenitors forming entire hair follicles
could be readily demonstrated by similar assays with pri-
mary keratinocytes derived from p21/ mice (Topley et al,
1999) (Fig 2).
Exposure of primary keratinocytes to increased extra-
cellular calcium concentrations induces a differentiation
program similar to that occurring in vivo, including estab-
lishment of adherens junctions and desmosomes, induction
of several enzymatic and structural markers of the upper
epidermal layers and exit from the cell cycle (Dotto, 1999).
Importantly, establishment of this differentiation program
can be reversed at early times (within 24 h) by simple re-
moval of the calcium pro-differentiation stimulus, and only
at later times (2–3 d and beyond) differentiation becomes
irreversible. p21 appears also to be a critical determinant of
the irreversibility of differentiation, as a significant fraction of
primary keratinocytes from p21/ mice (15%–30%), but
not wild-type cells, can resume proliferation even after 3–6
d of exposure to elevated extracellular calcium (Topley et al,
1999).
Thus, although not essential for exit of the vast majority
of ‘‘transit amplifying’’ keratinocytes from the cell cycle, p21
plays a key role in restricting the number of keratinocyte
Figure2
Hair follicle reconstitution potential of p21þ /þ versus p21/
primary keratinocytes. Summary of the results obtained by skin/hair
reconstitution assays with primary keratinocytes genetically labeled by
infection with a retrovirus transducing the alkaline phosphatase (AP)
marker gene (Topley et al, 1999). Experiments were performed with
primary keratinocytes derived from either p21þ /þ or p21/ mice of
the same genetic background. In each case, mixed populations of ap-
proximately 10% infected and 90% uninfected keratinocytes were
grafted together with hair-inducing dermal papilla cells. Mice were eu-
thanized 6 weeks after grafting (with reconstituted hair follicles having
undergone three hair cycles), and hair follicles in cross section were
counted for numbers that consisted of homogeneously AP-positive
cells (consistent with being derived from single progenitors) versus
numbers of follicles composed of both AP-positive and AP-negative
populations (likely to be derived from multiple progenitors).
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stem cell populations (as determined by clonogenicity and
skin/hair reconstitution assays) as well as, further down-
stream, determining the irreversibility of differentiation.
Thus, p21 may exert these functions by acting at two dis-
tinct levels (increasing k1/k2 as well as k5 in Fig 1). On the
basis of our dynamic model, however, the same balance of
keratinocyte stem cells versus committed populations
could be achieved if p21 were to act at a single level (i.e.
by simply increasing k5 in Fig 1).
Notch1, a direct upstream regulator of p21 expression,
plays a key role in the coordinate control of keratinocyte
self renewal and differentiation The Notch gene family
encodes evolutionarily conserved transmembrane recep-
tors with a key role in cell-fate determination and differen-
tiation (Artavanis-Tsakonas et al, 1999). Notch activation is
triggered by interactions with ligands of the Delta and Ser-
rate/Jagged families, and results in release of the intracel-
lular region of the receptor by proteolytic cleavage and
nuclear translocation (Artavanis-Tsakonas et al, 1999). The
activated Notch intracellular region binds to a ubiquitous
DNA-binding protein of the CSL family (Drosophila Sup-
pressor of hairless (Su(H)) or its mammalian homolog RBP-
Jk/CBF1), converting it from a repressor into an activator of
transcription (Lai, 2002). Notch activation results in the in-
duction of a program of gene expression that can either
suppress or promote differentiation in a cell type- and con-
text-dependent manner (Artavanis-Tsakonas et al, 1999).
Most work has focused on the ability of Notch to direct
divergent pathways of differentiation among initially equip-
otent cells (Fig 3A). One-way Notch and ligands such as
Delta act to promote divergent differentiation is termed lat-
eral inhibition, a mechanism first described and character-
ized in the developing neuroectoderm of Drosophila
(Muskavitch, 1994). Notch and its ligands, however, can al-
so be co-expressed in the same cells undergoing coordi-
nate differentiation to a single fate (Fig 3B). Examples of
such cells include those in developing mammalian muscle
and skin, in which the Serrate-like ligands Jagged 1 and 2
are co-expressed with Notch (Luo et al, 1997). In this con-
text, the Notch-dependent upregulation of Jagged1 ex-
pression has been proposed to function as a positive
feedback mechanism, similar to that reported for Drosophi-
la (de Celis and Bray, 1997), for the coordinate control of
differentiation along the same cell lineage (Luo et al, 1997).
The relative contribution of negative and positive feedback
mechanisms for modulation of Notch signaling appears to
be further controlled by ancillary proteins, such as members
of the Fringe family that selectively inhibit Notch respon-
siveness to Serrate-like ligands (Fleming et al, 1997; Panin
et al, 1997).
A variety of data suggest that all these mechanisms for
regulation of Notch activity operate in mammalian skin. A
complex pattern of expression of Notch and its ligands is
seen in hair follicles and feathers, consistent with their mul-
tiple keratinocyte cell lineages (Kopan and Weintraub, 1993;
Favier et al, 2000). A role for Notch in keratinocyte skin ap-
pendages formation and/or differentiation is supported by
ectopic expression of Notch or its ligands, with Notch ac-
tivation in one layer of the hair follicle modulating differen-
tiation and/or lineage commitment in neighboring layers
(Crowe et al, 1998; Viallet et al, 1998; Lin et al, 2000; Lowell
et al, 2000). In human interfollicular epidermis, localized
expression of Delta in putative ‘‘stem cells’’ has been pro-
posed to induce commitment of neighboring Notch1-
expressing cells to a ‘‘transit amplifying’’ phenotype, a sce-
nario reminiscent of lateral inhibition (Lowell et al, 2000). On
the other hand, consistent with previous results in devel-
oping murine epidermis (Luo et al, 1997), we have found
that in newborn mouse epidermis high expression of Jag-
ged 1 and 2 coincide with Notch 1 and 2 in differentiating
keratinocytes of the supra-basal layers, with both Jagged 1/
2 and Notch1 expression being turned off in the terminally
differentiated outermost layers (Rangarajan et al, 2001b). In
mouse epidermis around birth, all three forms of Fringe are
expressed (Thelu et al, 1998). Of note, the spinous layer is
the only region of the epidermis free of Fringe expression,
thereby potentially creating a Notch signaling boundary be-
tween this layer and cells of the immediately underlying
(basal) and overlying (granular) layers (Thelu et al, 1998).
An essential role of Notch1 in epidermal border formation
was demonstrated by the analysis of mice with a conditional
keratinocyte-specific deletion of this gene. Loss of Notch1
results in an hyperplastic phenotype of the interfollicular
epidermis, with inappropriate co-expression of keratins of
the basal and upper epidermal layers, and a striking up-
regulation of integrin b1 and b4 expression in the supra-
basal epidermal layers, where expression of these integrins
is usually low or undetectable (Rangarajan et al, 2001). Ad-
ditionally, endogenous Notch1 activity is required for
induction of p21 expression in differentiation. In fact, in
mouse keratinocytes, the p21 gene is a direct transcrip-
tional target of Notch1 activation. p21 expression is induced
in these cells by activated Notch1 through RBP-Jk-
dependent transcription, and the RBP-Jk protein binds di-
rectly to the endogenous p21 promoter (Rangarajan et al,
2001). Importantly, Notch1 activity itself is induced in par-
allel with p21 expression in the transition between transit
amplifying and differentiating cells (Fig 4A). In turn, in-
creased Notch1 activity can also induce differentiation,
Figure 3
Notch signaling in determination of cell fate and stem cell poten-
tial. As discussed in the text, there are two possible modes of action of
Notch signaling, lateral inhibition (A) and positive reinforcement (B), that
are determined by either a negative or positive feedback loop between
expression of Notch (N) and its ligands, Delta (D) or Jagged (J).
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through a mechanism likely to involve down-regulation of
integrin a6/b4 and a3/b1 expression (Rangarajan et al, 2001)
(Fig 4B). Thus, Notch1 can function both upstream and in
parallel with p21 in regulating the balance between kera-
tinocyte stem cells and more committed populations. Like
p21, Notch1 may exert this function acting at distinct mul-
tiple levels (increasing k1/k2 as well as k5 in Fig 1), but the
same end result could be achieved if Notch1, like p21, were
to act at a single level (i.e. only increasing k5).
Future directions: p21 and Notch1 as keratinocyte
tumor suppressors Keratinocyte stem cells are the puta-
tive targets for mouse skin carcinogenesis (Morris et al,
1997). Consistent with an increased size of stem cell pop-
ulations, mice with a disruption of the p21 gene exhibit a
substantially enhanced susceptibility to chemically induced
skin carcinogenesis, with an increase numbers of tumors
that are either malignant or benign, depending on protocol
and genetic background (Cheng et al, 1999; Topley et al,
1999; Weinberg et al, 1999). In parallel with these findings,
primary keratinocytes from p21/ mice are highly sus-
ceptible to ras-oncogene malignant transformation (Missero
et al, 1996). Strikingly, as for mice lacking the p21WAF1/Cip1
gene, mice with induced deletion of Notch1 exhibit a sub-
stantially increased susceptibility to chemically-induced
skin carcinogenesis and, as with p21/ cells, Notch1/
 keratinocytes infected with a retrovirus transducing the
ras oncogene and injected subcutaneously into nude
mice form aggressive squamous cell carcinomas, whereas
Notch1þ /þ cells do not (Nicolas et al, 2003).
Although p21 is one of the important downstream targets
of Notch function in keratinocytes, Notch signaling is likely
to affect other signaling pathways with a key regulatory
function in this cell type. In fact, mice with an induced de-
letion of the Notch1 gene differ in other aspects of their
phenotype from p21/ animals. In particular, mice with
the Notch1 deletion develop after 3 mo of age extensive
hyperplasia and keratinization of the corneal epithelium that
results in opaque plaque formation and blindness. Concur-
rently, they develop also spontaneous skin tumors in various
parts of the body that are highly vascularized and consist of
small proliferating basophilic cells similar to those in basal
cell carcinomas (BCC) (Nicolas et al, 2003). In both hyper-
plastic epidermis and BCC-like tumors, Notch1 deficiency
is associated with increased and sustained expression of
Gli2, a downstream target of the sonic hedgehog (SHH)
signaling pathway that has been causally linked to BCC
tumor formation (Nicolas et al, 2003). Additionally, the Wnt/
b-catenin pathway appears to be elevated in keratinocytes
and tumors as a consequence of loss of Notch1 function,
whereas b-catenin signaling can be suppressed by activat-
ed Notch1 expression (Nicolas et al, 2003). Besides mod-
ulation of the SHH and WNT/b-catenin pathways, NF-kB
signaling is also increased (Nickoloff et al, 2002) and AP-1
signaling suppressed (Chu et al, 2002; Talora et al, 2002) in
keratinocytes with elevated Notch1 activity. Importantly, in-
hibition of the latter pathway has been recently connected
with a growth inhibitory function of Notch1 in an important
type of human keratinocyte-derived tumors: HPV-induced
cervical carcinomas (Talora et al, 2002).
Thus, an exciting area of study for the future is the close
interconnection among classical cell cycle and develop-
ment-related pathways in control of keratinocyte stem cell
potential, differentiation and tumorigenesis.
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